Skip to main content

Valganciclovir

ADVERTISEMENT
Identification
Molecular formula
C14H25N7O4
CAS number
175865-59-5
IUPAC name
3,6-diamino-N-[[15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
State
State

Valganciclovir is typically in a solid state at room temperature.

Melting point (Celsius)
148.00
Melting point (Kelvin)
421.15
Boiling point (Celsius)
230.00
Boiling point (Kelvin)
503.15
General information
Molecular weight
351.35g/mol
Molar mass
351.3490g/mol
Density
1.5800g/cm3
Appearence

Valganciclovir appears as a white to off-white powder. It is crystalline in nature and hygroscopic, which means it can absorb moisture from the air.

Comment on solubility

Solubility of 3,6-diamino-N-[[15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

The solubility of the compound with the formula C14H25N7O4 can be quite complex given its intricate structure and multiple functional groups. Understanding its solubility involves considering various factors:

  • Polar and Nonpolar Regions: The presence of both polar (e.g., amino groups, hydroxymethyl) and nonpolar regions may influence its solubility in different solvents.
  • Hydrogen Bonding: The ability of the compound to form hydrogen bonds could lead to enhanced solubility in polar solvents like water.
  • Molecular Size: As a larger molecular entity, the physical size can hinder solubility in certain solvents due to steric effects.

In general, compounds similar in structure may exhibit the following solubility characteristics:

  1. High solubility in water due to its polar functionalities.
  2. Limited solubility in organic solvents that do not support hydrogen bonding.
  3. Solubility can vary based on pH, as ionizable groups may change state.

In conclusion, the solubility of this complex compound is influenced by its structural characteristics, which dictate its interaction with various solvents. Therefore, practical solubility testing is essential to determine its behavior in specific environments.

Interesting facts

Interesting Facts about 3,6-diamino-N-[[15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

This intriguing compound reveals a unique structure that showcases the complexity of organic chemistry. The intricate arrangement of atoms indicates a role in biological systems that could entail significant functionality. Here are some remarkable aspects worth noting:

  • Structure Diversity: The presence of pentazacyclohexadec rings highlights the compound's structural diversity, which is rare and significant in chemical synthesis.
  • Biological Relevance: Compounds like this are often explored in the context of pharmaceuticals, particularly due to their potential interactions with biological macromolecules.
  • Functional Groups: The variety of functional groups in this molecule, such as amines and ureas, suggests that it may have various chemical reactivities that could be harnessed for different applications.
  • Research Potential: Given its complex architecture, this compound might serve as a template for developing new drugs or materials, making it a tantalizing subject for further research.

As a scientist delving into this compound, one may ask, "What unique properties could this molecule possess in a biological setting?" This question paves the way for rich exploration in medicinal chemistry and material science.

Ultimately, the study of such intricate compounds is vital as they hold keys to advances in various scientific domains. It reminds us that chemistry not only builds materials and medicines but also provides a framework for understanding life's complexities at a molecular level.

Synonyms
CAPREOMYCIN IA
Spectrum_001305
Spectrum2_000061
Spectrum3_000323
Spectrum4_001792
KBioGR_002366
KBioSS_001785
DivK1c_000279
SPBio_000241
CHEMBL3187605
KBio1_000279
KBio2_001785
KBio2_004353
KBio2_006921
KBio3_001145
NINDS_000279
(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide
NCGC00167473-05